Literature DB >> 20850579

Mechanical, biochemical and morphometric alterations in the femur of mdx mice.

Wilson Romero Nakagaki1, Celso Aparecido Bertran, Cintia Yuri Matsumura, Humberto Santo-Neto, José Angelo Camilli.   

Abstract

The bone tissue abnormalities observed in patients with Duchenne muscular dystrophy are frequently attributed to muscle weakness. In this condition, bones receive fewer mechanical stimuli, compromising the process of bone modeling. In the present study we hypothesize that other factors inherent to the disease might be associated with bone tissue impairment, irrespective of the presence of muscle impairment. Mdx mice lack dystrophin and present cycles of muscle degeneration/regeneration that become more intense in the third week of life. As observed in humans with muscular dystrophy, bone tissue abnormalities were found in mdx mice during more intense muscle degeneration due to age. Under these circumstances, muscle deficit is probably one of the factors promoting these changes. To test our hypothesis, we investigated the changes that occur in the femur of mdx mice at 21 days of age when muscle damage is still not significant. The mechanical (structural and material) and biochemical properties and morphometric characteristics of the femur of mdx and control animals were evaluated. The results demonstrated a lower strength, stiffness and energy absorption capacity in mdx femurs. Higher values for structural (load and stiffness) and material (stress, elastic modulus and toughness) properties were observed in the control group. Mdx femurs were shorter and were characterized by a smaller cortical area and thickness and a smaller area of epiphyseal trabecular bone. The hydroxyproline content was similar in the two groups, but there was a significant difference in the Ca/P ratios. Thermogravimetry showed a higher mineral matrix content in cortical bone of control animals. In conclusion, femurs of mdx mice presented impaired mechanical and biochemical properties as well as changes in collagen organization in the extracellular matrix. Thus, mdx mice developed femoral osteopenia even in the absence of significant muscle fiber degeneration. This weakness of the mdx femur is probably due to genetic factors that are directly or indirectly related to dystrophin deficiency. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20850579     DOI: 10.1016/j.bone.2010.09.011

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  18 in total

1.  Prednisolone treatment and restricted physical activity further compromise bone of mdx mice.

Authors:  S A Novotny; G L Warren; A S Lin; R E Guldberg; K A Baltgalvis; D A Lowe
Journal:  J Musculoskelet Neuronal Interact       Date:  2012-03       Impact factor: 2.041

2.  Metabolic and structural bone disturbances induced by hyperlipidic diet in mice treated with simvastatin.

Authors:  Evelise Aline Soares; Rômulo Dias Novaes; Wilson Romero Nakagaki; Geraldo José Medeiros Fernandes; José Antônio Dias Garcia; José Angelo Camilli
Journal:  Int J Exp Pathol       Date:  2015-07-14       Impact factor: 1.925

3.  Osteoporosis genetics: year 2011 in review.

Authors:  David Karasik; Miri Cohen-Zinder
Journal:  Bonekey Rep       Date:  2012-08-01

4.  Insights into bone health in Duchenne muscular dystrophy.

Authors:  Victor H Morgenroth; Lauren P Hache; Paula R Clemens
Journal:  Bonekey Rep       Date:  2012-02-01

5.  Renal involvement in the pathogenesis of mineral and bone disorder in dystrophin-deficient mdx mouse.

Authors:  Eiji Wada; Takayuki Hamano; Isao Matsui; Mizuko Yoshida; Yukiko K Hayashi; Ryoichi Matsuda
Journal:  J Physiol Sci       Date:  2019-05-11       Impact factor: 2.781

6.  Delayed bone regeneration is linked to chronic inflammation in murine muscular dystrophy.

Authors:  Rana Abou-Khalil; Frank Yang; Marie Mortreux; Shirley Lieu; Yan-Yiu Yu; Maud Wurmser; Catia Pereira; Frédéric Relaix; Theodore Miclau; Ralph S Marcucio; Céline Colnot
Journal:  J Bone Miner Res       Date:  2014-02       Impact factor: 6.741

7.  Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities.

Authors:  Christian Isaac; Adam Wright; Arvydas Usas; Hongshuai Li; Ying Tang; Xiaodong Mu; Nicholas Greco; Qing Dong; Nam Vo; James Kang; Bing Wang; Johnny Huard
Journal:  J Orthop Res       Date:  2012-10-23       Impact factor: 3.494

8.  Musculoskeletal response of dystrophic mice to short term, low intensity, high frequency vibration.

Authors:  S A Novotny; M D Eckhoff; B C Eby; J A Call; D Nuckley; D A Lowe
Journal:  J Musculoskelet Neuronal Interact       Date:  2013-12       Impact factor: 2.041

9.  Systemic investigation of bone and muscle abnormalities in dystrophin/utrophin double knockout mice during postnatal development and the mechanisms.

Authors:  Xueqin Gao; Ying Tang; Sarah Amra; Xuying Sun; Yan Cui; Haizi Cheng; Bing Wang; Johnny Huard
Journal:  Hum Mol Genet       Date:  2019-05-15       Impact factor: 6.150

10.  Scleraxis is required for the development of a functional tendon enthesis.

Authors:  Megan L Killian; Stavros Thomopoulos
Journal:  FASEB J       Date:  2015-10-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.